ORBIMED ADVISORS LLC ORIC Pharmaceuticals, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$6.68M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

-28.57%
quarter

ORIC Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -2.67M $3.2 2.08M
Q2 2022 share 0.00% 0 shares -1.79M $4.48 2.08M
Q1 2022 share Decrease -10.70% -250.00K shares -23.21M $5.34 2.08M
Q4 2021 share 0.00% 0 shares -14.51M $15.59 2.33M
Q3 2021 share 0.00% 0 shares 7.52M $20.91 2.33M
Q2 2021 share 0.00% 0 shares -15.91M $17.69 2.33M
Q1 2021 share Decrease -20.00% -584.39K shares -41.63M $24.5 2.33M
Q4 2020 share 0.00% 0 shares 25.83M $33.85 2.92M
Q3 2020 share 0.00% 0 shares -25.48M $25.01 2.92M
Q2 2020 share Increase 0.00% 2.92M shares 98.55M $33.73 2.92M